These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1434 related articles for article (PubMed ID: 17982939)
1. Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression. Casoli C; Pilotti E; Bertazzoni U AIDS Rev; 2007; 9(3):140-9. PubMed ID: 17982939 [TBL] [Abstract][Full Text] [Related]
2. HIV/human T-cell lymphotropic virus coinfection revisited: impact on AIDS progression. Brites C; Sampalo J; Oliveira A AIDS Rev; 2009; 11(1):8-16. PubMed ID: 19290030 [TBL] [Abstract][Full Text] [Related]
3. Influence of human T cell lymphotropic virus type 2 coinfection on virological and immunological parameters in HIV type 1-infected patients. Bassani S; López M; Toro C; Jiménez V; Sempere JM; Soriano V; Benito JM Clin Infect Dis; 2007 Jan; 44(1):105-10. PubMed ID: 17143825 [TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes and disease progression among patients coinfected with HIV and human T lymphotropic virus types 1 and 2. Beilke MA; Theall KP; O'Brien M; Clayton JL; Benjamin SM; Winsor EL; Kissinger PJ Clin Infect Dis; 2004 Jul; 39(2):256-63. PubMed ID: 15307036 [TBL] [Abstract][Full Text] [Related]
5. Relationship between human T lymphotropic virus (HTLV) type 1/2 viral burden and clinical and treatment parameters among patients with HIV type 1 and HTLV-1/2 coinfection. Beilke MA; Traina-Dorge VL; Sirois M; Bhuiyan A; Murphy EL; Walls JM; Fagan R; Winsor EL; Kissinger PJ Clin Infect Dis; 2007 May; 44(9):1229-34. PubMed ID: 17407044 [TBL] [Abstract][Full Text] [Related]
6. High levels of CC-chemokine expression and downregulated levels of CCR5 during HIV-1/HTLV-1 and HIV-1/HTLV-2 coinfections. Oo Z; Barrios CS; Castillo L; Beilke MA J Med Virol; 2015 May; 87(5):790-7. PubMed ID: 25678365 [TBL] [Abstract][Full Text] [Related]
7. The clinical significance of HTLV-I and HTLV-II infection in the AIDS epidemic. Pierik LT; Murphy EL AIDS Clin Rev; 1991; ():39-57. PubMed ID: 1868010 [TBL] [Abstract][Full Text] [Related]
8. In vitro induction of HIV-1 replication in resting CD4(+) T cells derived from individuals with undetectable plasma viremia upon stimulation with human T-cell leukemia virus type I. Moriuchi H; Moriuchi M Virology; 2000 Dec; 278(2):514-9. PubMed ID: 11118373 [TBL] [Abstract][Full Text] [Related]
9. The epidemiology and disease outcomes of human T-lymphotropic virus type II. Roucoux DF; Murphy EL AIDS Rev; 2004; 6(3):144-54. PubMed ID: 15595431 [TBL] [Abstract][Full Text] [Related]
10. Coinfection with HIV-1 and human T-Cell lymphotropic virus type II in intravenous drug users is associated with delayed progression to AIDS. Turci M; Pilotti E; Ronzi P; Magnani G; Boschini A; Parisi SG; Zipeto D; Lisa A; Casoli C; Bertazzoni U J Acquir Immune Defic Syndr; 2006 Jan; 41(1):100-6. PubMed ID: 16340481 [TBL] [Abstract][Full Text] [Related]
11. Attenuation of HIV-1 infection by other microbial agents. Kannangara S; DeSimone JA; Pomerantz RJ J Infect Dis; 2005 Sep; 192(6):1003-9. PubMed ID: 16107952 [TBL] [Abstract][Full Text] [Related]
12. Neurological aspects of HIV/human T lymphotropic virus coinfection. Tulius Silva M; de Melo Espíndola O; Bezerra Leite AC; Araújo A AIDS Rev; 2009; 11(2):71-8. PubMed ID: 19529747 [TBL] [Abstract][Full Text] [Related]
13. Co-infection by the human T-cell lymphotropic virus type II in patients infected by the human immunodeficiency virus in Yucatan, Mexico. Castro-Sansores CJ; Santos-Rivero A; González-Martínez P; Lara-Perera DM; Alonso-Salomon G; Gongora-Biachi RA Arch Med Res; 2006 Apr; 37(3):365-9. PubMed ID: 16513486 [TBL] [Abstract][Full Text] [Related]
14. Co-infection with HIV-1/HTLV-II and the risk of progression to AIDS and death. The Oslo HIV Cohort Study Group. Eskild A; Samdal HH; Heger B APMIS; 1996 Sep; 104(9):666-72. PubMed ID: 8972691 [TBL] [Abstract][Full Text] [Related]
15. Long-term variations in human T lymphotropic virus (HTLV)-I and HTLV-II proviral loads and association with clinical data. Kwaan N; Lee TH; Chafets DM; Nass C; Newman B; Smith J; Garratty G; Murphy EL; J Infect Dis; 2006 Dec; 194(11):1557-64. PubMed ID: 17083040 [TBL] [Abstract][Full Text] [Related]
16. HTLV infection among young injection and non-injection heroin users in Spain: prevalence and correlates. de la Fuente L; Toro C; Soriano V; Brugal MT; Vallejo F; Barrio G; Jiménez V; Silva T; J Clin Virol; 2006 Mar; 35(3):244-9. PubMed ID: 16143565 [TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus permissively infects human syncytiotrophoblasts in vitro and induces replication of human T cell leukemia-lymphoma virus type I in dually infected cells. Tóth FD; Aboagye-Mathiesen G; Nemes J; Liu X; Andirkó I; Hager H; Zdravkovic M; Szabó J; Kiss J; Aranyosi J; Ebbesen P Virology; 1997 Mar; 229(2):400-14. PubMed ID: 9126252 [TBL] [Abstract][Full Text] [Related]
18. Tropical spastic paraparesis/human T leukemia virus type 1-associated myelopathy in HIV type 1-coinfected patients. Beilke MA; Japa S; Moeller-Hadi C; Martin-Schild S Clin Infect Dis; 2005 Sep; 41(6):e57-63. PubMed ID: 16107970 [TBL] [Abstract][Full Text] [Related]
19. HTLV-2b among HIV type 1-coinfected injecting drug users in Spain. Abad M; Dronda F; Dominguez E; Moreno S; Vallejo A AIDS Res Hum Retroviruses; 2011 May; 27(5):579-83. PubMed ID: 20854172 [TBL] [Abstract][Full Text] [Related]
20. Increased hepatitis C virus load among injection drug users infected with human immunodeficiency virus and human T lymphotropic virus type II. Hisada M; Chatterjee N; Zhang M; Battjes RJ; Goedert JJ J Infect Dis; 2003 Sep; 188(6):891-7. PubMed ID: 12964121 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]